CryoPort, Inc. CYRX Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by CryoPort, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: CryoPort, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CryoPort, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CryoPort, Inc.'s cash & equivalents?
- CryoPort, Inc. (CYRX) reported cash & equivalents of $272.91M in Q1 2026.
- How has CryoPort, Inc.'s cash & equivalents changed year-over-year?
- CryoPort, Inc.'s cash & equivalents increased by 655.9% year-over-year, from $36.1M to $272.91M.
- What is the long-term trend for CryoPort, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), CryoPort, Inc.'s cash & equivalents has grown at a 46.7% compound annual growth rate (CAGR), from $36.87M to $250.49M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.